Long-Term In-Center Nocturnal Hemodialysis Improves Renal Anemia and Malnutrition and Life Quality of Older Patients with Chronic Renal Failure
Yu Gong,Liangyu Xie,Shengqiang Yu
DOI: https://doi.org/10.2147/CIA.S358472
IF: 3.829
2022-06-03
Clinical Interventions in Aging
Abstract:Yu Gong, 1, &ast Liangyu Xie, 2, &ast Shengqiang Yu 2 1 Department of Internal Medicine, Division of Nephrology, Telemedicine Center, Shanghai Municipal Eighth People's Hospital, Shanghai, People's Republic of China; 2 Department of Internal Medicine, Division of Nephrology, Shanghai Changzheng Hospital, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yu Gong, Department of Internal medicine, Division of Nephrology, Telemedicine Center, Shanghai Municipal Eighth People's Hospital, 8 Caobao Road, Shanghai, 200235, People's Republic of China, Tel +86-18930718612, Email Shengqiang Yu, Department of Internal Medicine, Division of Nephrology, Shanghai Changzheng Hospital, Shanghai, 200003, People's Republic of China, Tel +86-17301621966, Email Background: Older patients with chronic renal failure (CRF) which currently is referred to as end-stage renal disease (ESRD) are associated with higher mortality. In-center nocturnal dialysis (INHD) is a new blood purification model, which is characterized by longer sessions and nighttime administration. However, no data for the efficacy of INHD in older patients with ESRD are available. This study is to analyze the effect of INHD in the treatment of older patients with ESRD. Methods: A retrospective, observational study was conducted in a university teaching hospital. Seventy-two patients with ESRD receiving INHD were enrolled. They were divided into the older ESRD patients (age ≥ 60) group (n = 22) and the non-older ESRD patients (age < 60) group (n = 50). The causes of older ESRD patients and non-older ESRD patients receiving INHD were analyzed. Differences of laboratory test indicators of older patients with ESRD before INHD and after INHD were compared. Quality of life for older ESRD patients receiving INHD was assessed by using the Kidney Disease Quality of Life-36 Instrument (KDQOL-36). Results: Serum concentration of hemoglobin and serum concentration of albumin of older patients with ESRD increased significantly after INHD ( p < 0.05). There were similar results in the non-older cohort ( p ≤ 0.05). Scores of five KDQOL-36 subscales increased significantly after INHD ( p ≤ 0.001) indicated that the quality of life for old patients with ESRD was significantly improved after INHD. Conclusion: INHD is an effective blood purification therapy that can improve the condition of renal anemia, and it may provide a potential positive impact in the malnutrition of older and non-older patients with ESRD. INHD can improve the quality of life of older patients with ESRD. The results will provide a basis for formulating new policies of blood purification therapy for older patients. Keywords: older patients, chronic renal failure, CRF, end-stage renal disease, ESRD, in-center nocturnal hemodialysis, INHD, quality of life, nocturnal home hemodialysis, NHHD Older patients with chronic renal failure (CRF), which currently is referred to as end-stage renal disease (ESRD), are associated with higher mortality. Hemodialysis (HD) is one of the main methods of treatment for patients with ESRD, in which conventional hemodialysis (CHD; 3–4 hours per session, three times per week) is the most widely used hemodialysis treatment mode. In clinical practice, it is found that there are some defects in this hemodialysis treatment mode. In-center nocturnal hemodialysis (INHD; 7–8 hours per session, three times per week) is a new blood purification model, which is characterized by longer sessions and nighttime administration and may lead to better outcomes for some patients. 1 INHD has been applied in the treatment of patients with ESRD. Owing to its longer treatment duration-up to 7.5 hours per dialysis treatment-in-center thrice-weekly, INHD is receiving greater attention, 2 and scholars have conducted relevant researches on this new blood purification mode. 3–6 It has been found that INHD was associated with improvements in several clinically relevant outcomes compared to that of CHD and no pre-specified outcome was worse with INHD. 7 However, most clinical studies of INHD are aimed at patients of all age groups and clinical research on older patients with ESRD receiving INHD has not been reported. The older patients with ESRD receiving INHD are a special patient group whose health status, nutritional status, immunity and organs' function are significantly different from that of patients from other age groups. Human society has entered the age of aging, and the number of older patients with ESRD receiving HD treatment is increasing significantly. However, no data for the efficacy of INHD in older -Abstract Truncated-
geriatrics & gerontology,gerontology